SARS-CoV-2 Nucleocapsid Antikörper
Kurzübersicht für SARS-CoV-2 Nucleocapsid Antikörper (ABIN7211717)
Target
Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- SARS-CoV-2 Nucleocapsid Protein
-
Kreuzreaktivität (Details)
- no cross reactivity observed
-
Aufreinigung
- affinity chromatography, protein A
-
Immunogen
- SARS-CoV-2 Nucleocapsid Protein
-
-
-
-
Applikationshinweise
- 0.05 μg or less for indirect ELISA 0.1 μg for capture in sandwich ELISA 0.05 μg for detection in sandwich ELISA optimal dilution must be determined by end-user
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Frozen, Liquid
-
Buffer
- PBS, pH 7.3, 0.1 % Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Andere Bezeichnung
- SARS-CoV-2 Nucleoprotein
-
Substanzklasse
- Influenza Protein
-
Hintergrund
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly-discovered the strain of Lineage B of Betacoronaviruses causing coronavirus disease 2019 (COVID-19). SARS-CoV-2 is a positive-sense single stranded RNA virus infecting humans and spreading between people through close contact and via respiratory droplets produced from coughs, sneezes and even speaking. It enters human cells by binding to the receptor angiotensin converting enzyme 2 (ACE2). The Nucleocapsid protein is a structural protein holding the RNA genome.
-
Molekulargewicht
- 48 kDa
Target
-